NASDAQ NMS - GLOBAL MARKET · FBRX
+0.07% · +$0.0500 · Vol 1.4M
After hours · updated 16:00:06 ET
Forte Biosciences Inc

Forte Biosciences Inc

Biotechnology
$76.61
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
FBRX
Forte Biosciences Inc
Tue Aug 4 · last completed session · Markets closed · resumes Thu 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

69/ 100
Veridion Score
BUY BIAS · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Tue Aug 4 · last completed session · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is FBRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading FBRX catalysts
About Forte Biosciences Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2020
Employees
22
Country
US

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$76.60
Day high
$76.68
Day low
$76.56
Previous close
$76.56
52W high
$76.98
-0.48% from high
52W low
$9.70
99% of range
Market cap
$1.6B
EPS
$-4.5600
Beta
0.42
Shares out
20.5M
Volume
1.4M
0.76× rel vol
Avg volume
1.8M
VWAP
$76.61
Price history computed in-house
1W
+0.10%
1M
+275.36%
3M
+192.74%
1Y
+689.79%
YTD
+180.93%
SMA 50 $34.04 · above
SMA 200 $27.04 · above
52W position 99%

FBRX overview

Veridion Score
69
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around FBRX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading FBRX Form 4 filings
Public disclosures

Congress activity in FBRX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for FBRX in the cached public ledger.

Federal contracts

FBRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for FBRX in this window.
Lobbying spend

FBRX lobbying filings, year to date.

Registered lobbying filings matched to Forte Biosciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for FBRX in this window.
Loading news for FBRX
Analyst ratings
Sovereign unlock shows live analyst consensus for FBRX.
Options
Sovereign unlock shows live options positioning for FBRX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.